Improved speed of evaporation, shorter condenser defrost time, more powerful software, and the flexibility to accommodate a wide range of sample formats
Ideal for medicinal chemistry and other drug discovery research applications, the Genevac model DD-4X is the latest cost-effective system for general-purpose centrifugal solvent evaporation.
Improved speed of evaporation, shorter condenser defrost time, more powerful software (including remote control functions) and the flexibility to accommodate a wide range of sample formats are key benefits of the new model DD-4X.
The new DD-4X has a redesigned chamber, which together with powerful IR lamps, dramatically increases the speed of evaporation, even for high boiling point solvents such as DMSO and NMP.
In addition, better chamber cooling between runs is particularly useful to protect thermally sensitive samples when run immediately after higher boiling point solvents.
To improve high-throughput capability the waste solvent condenser chamber volume on the DD-4X has been raised and the condenser power increased by 50%. These modifications enable better overall solvent recovery, shorter run times and have reduced condenser defrost times by a third.
Together these factors ensure maximum performance throughout the run.
Flexibility to accommodate a wide range of sample formats is at the heat of the model DD-4X.
Interchangeable high performance, solid aluminium rotors offer high capacity handling of test tubes and vials.
Alternatively, a swing rotor will accommodate tubes, vials, microtitre plates and Fast-Stack multi-deck microplate holders.
Benefiting from an optimised layout and new electronics the DD-4X is highly reliability and offers simple maintenance access, helping to extend system life and reduce the cost of ownership.
